Načítá se...
Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma
Gold glyconanoparticles loaded with the listeriolysin O peptide 91–99 (GNP-LLO(91-99)), a bacterial peptide with anti-metastatic properties, are vaccine delivery platforms facilitating immune cell targeting and increasing antigen loading. Here, we present proof of concept analyses for the considerat...
Uloženo v:
| Vydáno v: | Oncoimmunology |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6343812/ https://ncbi.nlm.nih.gov/pubmed/30713801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1541534 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|